401k Plan data: PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN plan

PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN 401k Plan overview

Plan Name	PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN
Plan identification number	001

PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.

401k Sponsoring company profile

PHARMACEUTICAL TECHNOLOGIES, INC. has sponsored the creation of one or more 401k plans.

Company Name: PHARMACEUTICAL TECHNOLOGIES, INC.

Employer identification number (EIN): 470818115

NAIC Classification: 524290

Additional information about PHARMACEUTICAL TECHNOLOGIES, INC.

Jurisdiction of Incorporation: Washington Secretary of State Corporations Division

Incorporation Date: 2014-06-18

Company Identification Number: 603412528

Legal Registered Office Address: 300 DESCHUTES WAY SW STE 208 MC-CSC1

TUMWATER
United States of America (USA)
98501

More information about PHARMACEUTICAL TECHNOLOGIES, INC.

Form 5500 Filing Information

Submission information for form 5500 for 401k plan PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
001 2019-01-01
001 2018-01-01
001 2017-01-01 AMY THOMAS
001 2016-01-01 SHELLIE SCHOENING
001 2015-01-01 KERRI PLUMMER-GELECKI
001 2014-01-01 APRIL STRONG APRIL STRONG 2015-07-31
001 2013-01-01 APRIL STRONG APRIL STRONG 2014-07-29
001 2012-01-01 CHRISTINA LAFEVER CHRISTINA LAFEVER 2013-11-27
001 2011-01-01 ANGELLA PIEPER 2012-07-20 ANGELLA PIEPER 2012-07-20
001 2010-01-01 ANGELLA PIEPER 2011-06-28 ANGELLA PIEPER 2011-06-28

Plan id#	Filing Submission Date	Name of Administrator	Date Administrator Signed	Name of Company Sponsor	Date Sponsor Signed
001	2019-01-01
001	2018-01-01
001	2017-01-01	AMY THOMAS
001	2016-01-01	SHELLIE SCHOENING
001	2015-01-01	KERRI PLUMMER-GELECKI
001	2014-01-01	APRIL STRONG		APRIL STRONG	2015-07-31
001	2013-01-01	APRIL STRONG		APRIL STRONG	2014-07-29
001	2012-01-01	CHRISTINA LAFEVER		CHRISTINA LAFEVER	2013-11-27
001	2011-01-01	ANGELLA PIEPER	2012-07-20	ANGELLA PIEPER	2012-07-20
001	2010-01-01	ANGELLA PIEPER	2011-06-28	ANGELLA PIEPER	2011-06-28

Plan Statistics for PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN

401k plan membership statisitcs for PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN

Measure Date Value
2019: PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN 2019 401k membership
Total participants, beginning-of-year 2019-01-01 144
Total number of active participants reported on line 7a of the Form 5500 2019-01-01 0
Total of all active and inactive participants 2019-01-01 0
Total participants 2019-01-01 0
Number of participants with account balances 2019-01-01 0
2018: PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN 2018 401k membership
Total participants, beginning-of-year 2018-01-01 179
Total number of active participants reported on line 7a of the Form 5500 2018-01-01 0
Number of other retired or separated participants entitled to future benefits 2018-01-01 144
Total of all active and inactive participants 2018-01-01 144
Total participants 2018-01-01 144
Number of participants with account balances 2018-01-01 144
2017: PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN 2017 401k membership
Total participants, beginning-of-year 2017-01-01 187
Total number of active participants reported on line 7a of the Form 5500 2017-01-01 128
Number of retired or separated participants receiving benefits 2017-01-01 0
Number of other retired or separated participants entitled to future benefits 2017-01-01 43
Total of all active and inactive participants 2017-01-01 171
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2017-01-01 0
Total participants 2017-01-01 171
Number of participants with account balances 2017-01-01 168
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2017-01-01 7
2016: PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN 2016 401k membership
Total participants, beginning-of-year 2016-01-01 165
Total number of active participants reported on line 7a of the Form 5500 2016-01-01 138
Number of retired or separated participants receiving benefits 2016-01-01 0
Number of other retired or separated participants entitled to future benefits 2016-01-01 39
Total of all active and inactive participants 2016-01-01 177
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2016-01-01 0
Total participants 2016-01-01 177
Number of participants with account balances 2016-01-01 177
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2016-01-01 15
2015: PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN 2015 401k membership
Total participants, beginning-of-year 2015-01-01 157
Total number of active participants reported on line 7a of the Form 5500 2015-01-01 137
Number of retired or separated participants receiving benefits 2015-01-01 0
Number of other retired or separated participants entitled to future benefits 2015-01-01 19
Total of all active and inactive participants 2015-01-01 156
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2015-01-01 0
Total participants 2015-01-01 156
Number of participants with account balances 2015-01-01 139
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2015-01-01 20
2014: PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN 2014 401k membership
Total participants, beginning-of-year 2014-01-01 159
Total number of active participants reported on line 7a of the Form 5500 2014-01-01 145
Number of retired or separated participants receiving benefits 2014-01-01 0
Number of other retired or separated participants entitled to future benefits 2014-01-01 9
Total of all active and inactive participants 2014-01-01 154
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2014-01-01 0
Total participants 2014-01-01 154
Number of participants with account balances 2014-01-01 135
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2014-01-01 11
2013: PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN 2013 401k membership
Total participants, beginning-of-year 2013-01-01 147
Total number of active participants reported on line 7a of the Form 5500 2013-01-01 140
Number of retired or separated participants receiving benefits 2013-01-01 0
Number of other retired or separated participants entitled to future benefits 2013-01-01 8
Total of all active and inactive participants 2013-01-01 148
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2013-01-01 0
Total participants 2013-01-01 148
Number of participants with account balances 2013-01-01 129
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2013-01-01 16
2012: PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN 2012 401k membership
Total participants, beginning-of-year 2012-01-01 121
Total number of active participants reported on line 7a of the Form 5500 2012-01-01 132
Number of retired or separated participants receiving benefits 2012-01-01 0
Number of other retired or separated participants entitled to future benefits 2012-01-01 5
Total of all active and inactive participants 2012-01-01 137
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2012-01-01 0
Total participants 2012-01-01 137
Number of participants with account balances 2012-01-01 120
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2012-01-01 12

Measure	Date	Value
2019: PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN 2019 401k membership
Total participants, beginning-of-year	2019-01-01	144
Total number of active participants reported on line 7a of the Form 5500	2019-01-01	0
Total of all active and inactive participants	2019-01-01	0
Total participants	2019-01-01	0
Number of participants with account balances	2019-01-01	0
2018: PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN 2018 401k membership
Total participants, beginning-of-year	2018-01-01	179
Total number of active participants reported on line 7a of the Form 5500	2018-01-01	0
Number of other retired or separated participants entitled to future benefits	2018-01-01	144
Total of all active and inactive participants	2018-01-01	144
Total participants	2018-01-01	144
Number of participants with account balances	2018-01-01	144
2017: PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN 2017 401k membership
Total participants, beginning-of-year	2017-01-01	187
Total number of active participants reported on line 7a of the Form 5500	2017-01-01	128
Number of retired or separated participants receiving benefits	2017-01-01	0
Number of other retired or separated participants entitled to future benefits	2017-01-01	43
Total of all active and inactive participants	2017-01-01	171
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2017-01-01	0
Total participants	2017-01-01	171
Number of participants with account balances	2017-01-01	168
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2017-01-01	7
2016: PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN 2016 401k membership
Total participants, beginning-of-year	2016-01-01	165
Total number of active participants reported on line 7a of the Form 5500	2016-01-01	138
Number of retired or separated participants receiving benefits	2016-01-01	0
Number of other retired or separated participants entitled to future benefits	2016-01-01	39
Total of all active and inactive participants	2016-01-01	177
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2016-01-01	0
Total participants	2016-01-01	177
Number of participants with account balances	2016-01-01	177
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2016-01-01	15
2015: PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN 2015 401k membership
Total participants, beginning-of-year	2015-01-01	157
Total number of active participants reported on line 7a of the Form 5500	2015-01-01	137
Number of retired or separated participants receiving benefits	2015-01-01	0
Number of other retired or separated participants entitled to future benefits	2015-01-01	19
Total of all active and inactive participants	2015-01-01	156
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2015-01-01	0
Total participants	2015-01-01	156
Number of participants with account balances	2015-01-01	139
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2015-01-01	20
2014: PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN 2014 401k membership
Total participants, beginning-of-year	2014-01-01	159
Total number of active participants reported on line 7a of the Form 5500	2014-01-01	145
Number of retired or separated participants receiving benefits	2014-01-01	0
Number of other retired or separated participants entitled to future benefits	2014-01-01	9
Total of all active and inactive participants	2014-01-01	154
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2014-01-01	0
Total participants	2014-01-01	154
Number of participants with account balances	2014-01-01	135
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2014-01-01	11
2013: PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN 2013 401k membership
Total participants, beginning-of-year	2013-01-01	147
Total number of active participants reported on line 7a of the Form 5500	2013-01-01	140
Number of retired or separated participants receiving benefits	2013-01-01	0
Number of other retired or separated participants entitled to future benefits	2013-01-01	8
Total of all active and inactive participants	2013-01-01	148
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2013-01-01	0
Total participants	2013-01-01	148
Number of participants with account balances	2013-01-01	129
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2013-01-01	16
2012: PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN 2012 401k membership
Total participants, beginning-of-year	2012-01-01	121
Total number of active participants reported on line 7a of the Form 5500	2012-01-01	132
Number of retired or separated participants receiving benefits	2012-01-01	0
Number of other retired or separated participants entitled to future benefits	2012-01-01	5
Total of all active and inactive participants	2012-01-01	137
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2012-01-01	0
Total participants	2012-01-01	137
Number of participants with account balances	2012-01-01	120
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2012-01-01	12

Financial Data on PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN

Measure	Date	Value
2019 : PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN 2019 401k financial data
Total unrealized appreciation/depreciation of assets	2019-01-02	$0
Total transfer of assets from this plan	2019-01-02	$5,050,194
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-01-02	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-01-02	$0
Total income from all sources (including contributions)	2019-01-02	$0
Total loss/gain on sale of assets	2019-01-02	$0
Total of all expenses incurred	2019-01-02	$0
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-01-02	$0
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-01-02	$0
Value of total assets at end of year	2019-01-02	$0
Value of total assets at beginning of year	2019-01-02	$5,050,194
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-01-02	$0
Total interest from all sources	2019-01-02	$0
Total dividends received (eg from common stock, registered investment company shares)	2019-01-02	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-01-02	No
Was this plan covered by a fidelity bond	2019-01-02	Yes
Value of fidelity bond cover	2019-01-02	$250,000
If this is an individual account plan, was there a blackout period	2019-01-02	Yes
Were there any nonexempt tranactions with any party-in-interest	2019-01-02	No
Participant contributions at beginning of year	2019-01-02	$47,839
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-01-02	No
Value of net income/loss	2019-01-02	$0
Value of net assets at end of year (total assets less liabilities)	2019-01-02	$0
Value of net assets at beginning of year (total assets less liabilities)	2019-01-02	$5,050,194
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-01-02	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-01-02	No
Were any leases to which the plan was party in default or uncollectible	2019-01-02	No
Value of interest in pooled separate accounts at beginning of year	2019-01-02	$4,927,181
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2019-01-02	$75,174
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-01-02	No
Was there a failure to transmit to the plan any participant contributions	2019-01-02	No
Has the plan failed to provide any benefit when due under the plan	2019-01-02	No
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2019-01-02	Yes
Did the plan have assets held for investment	2019-01-02	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-01-02	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-01-02	Yes
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-01-02	No
Opinion of an independent qualified public accountant for this plan	2019-01-02	Unqualified
Accountancy firm name	2019-01-02	PLANTE & MORAN, PLLC
Accountancy firm EIN	2019-01-02	381357951
2018 : PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN 2018 401k financial data
Total unrealized appreciation/depreciation of assets	2018-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total income from all sources (including contributions)	2018-12-31	$-39,454
Total loss/gain on sale of assets	2018-12-31	$0
Total of all expenses incurred	2018-12-31	$2,517,051
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2018-12-31	$2,505,273
Expenses. Certain deemed distributions of participant loans	2018-12-31	$7,092
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2018-12-31	$294,386
Value of total assets at end of year	2018-12-31	$5,050,194
Value of total assets at beginning of year	2018-12-31	$7,606,699
Total of administrative expenses incurred including professional, contract, advisory and management fees	2018-12-31	$4,686
Total interest from all sources	2018-12-31	$6,160
Total dividends received (eg from common stock, registered investment company shares)	2018-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2018-12-31	No
Was this plan covered by a fidelity bond	2018-12-31	Yes
Value of fidelity bond cover	2018-12-31	$250,000
If this is an individual account plan, was there a blackout period	2018-12-31	Yes
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2018-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2018-12-31	No
Contributions received from participants	2018-12-31	$199,729
Participant contributions at end of year	2018-12-31	$47,839
Participant contributions at beginning of year	2018-12-31	$112,347
Income. Received or receivable in cash from other sources (including rollovers)	2018-12-31	$521
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Value of net income/loss	2018-12-31	$-2,556,505
Value of net assets at end of year (total assets less liabilities)	2018-12-31	$5,050,194
Value of net assets at beginning of year (total assets less liabilities)	2018-12-31	$7,606,699
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2018-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2018-12-31	No
Were any leases to which the plan was party in default or uncollectible	2018-12-31	No
Value of interest in pooled separate accounts at end of year	2018-12-31	$4,927,181
Value of interest in pooled separate accounts at beginning of year	2018-12-31	$7,440,967
Interest on participant loans	2018-12-31	$4,272
Interest earned on other investments	2018-12-31	$1,888
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2018-12-31	$75,174
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2018-12-31	$53,385
Net investment gain/loss from pooled separate accounts	2018-12-31	$-340,000
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2018-12-31	No
Was there a failure to transmit to the plan any participant contributions	2018-12-31	No
Has the plan failed to provide any benefit when due under the plan	2018-12-31	No
Contributions received in cash from employer	2018-12-31	$94,136
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2018-12-31	$2,505,273
Contract administrator fees	2018-12-31	$4,686
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2018-12-31	Yes
Did the plan have assets held for investment	2018-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2018-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2018-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2018-12-31	Disclaimer
Accountancy firm name	2018-12-31	PLANTE & MORAN, PLLC
Accountancy firm EIN	2018-12-31	381357951
2017 : PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN 2017 401k financial data
Total unrealized appreciation/depreciation of assets	2017-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total income from all sources (including contributions)	2017-12-31	$2,032,818
Total loss/gain on sale of assets	2017-12-31	$0
Total of all expenses incurred	2017-12-31	$1,202,653
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2017-12-31	$1,198,105
Value of total corrective distributions	2017-12-31	$1,458
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2017-12-31	$950,240
Value of total assets at end of year	2017-12-31	$7,606,699
Value of total assets at beginning of year	2017-12-31	$6,776,534
Total of administrative expenses incurred including professional, contract, advisory and management fees	2017-12-31	$3,090
Total interest from all sources	2017-12-31	$4,882
Total dividends received (eg from common stock, registered investment company shares)	2017-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2017-12-31	No
Was this plan covered by a fidelity bond	2017-12-31	Yes
Value of fidelity bond cover	2017-12-31	$250,000
If this is an individual account plan, was there a blackout period	2017-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2017-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2017-12-31	No
Contributions received from participants	2017-12-31	$659,738
Participant contributions at end of year	2017-12-31	$112,347
Participant contributions at beginning of year	2017-12-31	$44,290
Income. Received or receivable in cash from other sources (including rollovers)	2017-12-31	$14,306
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Value of net income/loss	2017-12-31	$830,165
Value of net assets at end of year (total assets less liabilities)	2017-12-31	$7,606,699
Value of net assets at beginning of year (total assets less liabilities)	2017-12-31	$6,776,534
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2017-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2017-12-31	No
Were any leases to which the plan was party in default or uncollectible	2017-12-31	No
Value of interest in pooled separate accounts at end of year	2017-12-31	$7,440,967
Value of interest in pooled separate accounts at beginning of year	2017-12-31	$6,684,266
Interest on participant loans	2017-12-31	$3,732
Interest earned on other investments	2017-12-31	$1,150
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2017-12-31	$53,385
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2017-12-31	$47,978
Net investment gain/loss from pooled separate accounts	2017-12-31	$1,077,696
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2017-12-31	No
Was there a failure to transmit to the plan any participant contributions	2017-12-31	No
Has the plan failed to provide any benefit when due under the plan	2017-12-31	No
Contributions received in cash from employer	2017-12-31	$276,196
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2017-12-31	$1,198,105
Contract administrator fees	2017-12-31	$3,090
Did the plan have assets held for investment	2017-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2017-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2017-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2017-12-31	Disclaimer
Accountancy firm name	2017-12-31	BDO USA, LLP
Accountancy firm EIN	2017-12-31	135381590
2016 : PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN 2016 401k financial data
Total unrealized appreciation/depreciation of assets	2016-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$23,608
Total income from all sources (including contributions)	2016-12-31	$1,364,754
Total loss/gain on sale of assets	2016-12-31	$0
Total of all expenses incurred	2016-12-31	$920,265
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2016-12-31	$911,535
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2016-12-31	$1,022,742
Value of total assets at end of year	2016-12-31	$6,776,534
Value of total assets at beginning of year	2016-12-31	$6,355,653
Total of administrative expenses incurred including professional, contract, advisory and management fees	2016-12-31	$8,730
Total interest from all sources	2016-12-31	$5,201
Total dividends received (eg from common stock, registered investment company shares)	2016-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2016-12-31	No
Was this plan covered by a fidelity bond	2016-12-31	Yes
Value of fidelity bond cover	2016-12-31	$500,000
If this is an individual account plan, was there a blackout period	2016-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2016-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2016-12-31	No
Contributions received from participants	2016-12-31	$688,857
Participant contributions at end of year	2016-12-31	$44,290
Participant contributions at beginning of year	2016-12-31	$60,555
Income. Received or receivable in cash from other sources (including rollovers)	2016-12-31	$10,918
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2016-12-31	$23,608
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Value of net income/loss	2016-12-31	$444,489
Value of net assets at end of year (total assets less liabilities)	2016-12-31	$6,776,534
Value of net assets at beginning of year (total assets less liabilities)	2016-12-31	$6,332,045
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2016-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2016-12-31	No
Were any leases to which the plan was party in default or uncollectible	2016-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2016-12-31	$5,881,999
Value of interest in pooled separate accounts at end of year	2016-12-31	$6,684,266
Value of interest in pooled separate accounts at beginning of year	2016-12-31	$0
Interest on participant loans	2016-12-31	$2,337
Interest earned on other investments	2016-12-31	$2,864
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2016-12-31	$47,978
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2016-12-31	$413,099
Net investment gain/loss from pooled separate accounts	2016-12-31	$336,811
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2016-12-31	No
Was there a failure to transmit to the plan any participant contributions	2016-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2016-12-31	No
Contributions received in cash from employer	2016-12-31	$322,967
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2016-12-31	$911,535
Contract administrator fees	2016-12-31	$8,730
Did the plan have assets held for investment	2016-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2016-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2016-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2016-12-31	Disclaimer
Accountancy firm name	2016-12-31	RSM US LLP
Accountancy firm EIN	2016-12-31	420714325
2015 : PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN 2015 401k financial data
Total unrealized appreciation/depreciation of assets	2015-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$23,608
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$0
Total income from all sources (including contributions)	2015-12-31	$805,926
Total loss/gain on sale of assets	2015-12-31	$0
Total of all expenses incurred	2015-12-31	$406,696
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2015-12-31	$375,970
Value of total corrective distributions	2015-12-31	$2,835
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2015-12-31	$889,625
Value of total assets at end of year	2015-12-31	$6,355,653
Value of total assets at beginning of year	2015-12-31	$5,932,815
Total of administrative expenses incurred including professional, contract, advisory and management fees	2015-12-31	$27,891
Total interest from all sources	2015-12-31	$-83,699
Total dividends received (eg from common stock, registered investment company shares)	2015-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2015-12-31	No
Was this plan covered by a fidelity bond	2015-12-31	Yes
Value of fidelity bond cover	2015-12-31	$500,000
If this is an individual account plan, was there a blackout period	2015-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2015-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2015-12-31	No
Contributions received from participants	2015-12-31	$607,052
Participant contributions at end of year	2015-12-31	$60,555
Participant contributions at beginning of year	2015-12-31	$50,595
Income. Received or receivable in cash from other sources (including rollovers)	2015-12-31	$88,439
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2015-12-31	$23,608
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2015-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Value of net income/loss	2015-12-31	$399,230
Value of net assets at end of year (total assets less liabilities)	2015-12-31	$6,332,045
Value of net assets at beginning of year (total assets less liabilities)	2015-12-31	$5,932,815
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2015-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2015-12-31	No
Were any leases to which the plan was party in default or uncollectible	2015-12-31	No
Investment advisory and management fees	2015-12-31	$24,791
Value of interest in registered invesment companies (eg mutual funds) at end of year	2015-12-31	$5,881,999
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2015-12-31	$0
Value of interest in pooled separate accounts at end of year	2015-12-31	$0
Value of interest in pooled separate accounts at beginning of year	2015-12-31	$5,541,739
Interest on participant loans	2015-12-31	$2,484
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2015-12-31	$-86,183
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2015-12-31	$413,099
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2015-12-31	$340,481
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2015-12-31	No
Was there a failure to transmit to the plan any participant contributions	2015-12-31	No
Has the plan failed to provide any benefit when due under the plan	2015-12-31	No
Contributions received in cash from employer	2015-12-31	$194,134
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2015-12-31	$375,970
Contract administrator fees	2015-12-31	$3,100
Did the plan have assets held for investment	2015-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2015-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2015-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2015-12-31	Disclaimer
Accountancy firm name	2015-12-31	RSM US LLP
Accountancy firm EIN	2015-12-31	470714325
2014 : PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN 2014 401k financial data
Total unrealized appreciation/depreciation of assets	2014-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$0
Total income from all sources (including contributions)	2014-12-31	$968,552
Total loss/gain on sale of assets	2014-12-31	$0
Total of all expenses incurred	2014-12-31	$190,714
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2014-12-31	$165,566
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2014-12-31	$625,975
Value of total assets at end of year	2014-12-31	$5,932,815
Value of total assets at beginning of year	2014-12-31	$5,154,977
Total of administrative expenses incurred including professional, contract, advisory and management fees	2014-12-31	$25,148
Total interest from all sources	2014-12-31	$342,577
Total dividends received (eg from common stock, registered investment company shares)	2014-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2014-12-31	No
Was this plan covered by a fidelity bond	2014-12-31	Yes
Value of fidelity bond cover	2014-12-31	$500,000
If this is an individual account plan, was there a blackout period	2014-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2014-12-31	No
Contributions received from participants	2014-12-31	$506,490
Participant contributions at end of year	2014-12-31	$50,595
Participant contributions at beginning of year	2014-12-31	$89,996
Income. Received or receivable in cash from other sources (including rollovers)	2014-12-31	$27,895
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Value of net income/loss	2014-12-31	$777,838
Value of net assets at end of year (total assets less liabilities)	2014-12-31	$5,932,815
Value of net assets at beginning of year (total assets less liabilities)	2014-12-31	$5,154,977
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2014-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2014-12-31	No
Were any leases to which the plan was party in default or uncollectible	2014-12-31	No
Investment advisory and management fees	2014-12-31	$22,968
Value of interest in pooled separate accounts at end of year	2014-12-31	$5,541,739
Value of interest in pooled separate accounts at beginning of year	2014-12-31	$4,719,424
Interest on participant loans	2014-12-31	$2,904
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2014-12-31	$339,673
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2014-12-31	$340,481
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2014-12-31	$345,557
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2014-12-31	No
Was there a failure to transmit to the plan any participant contributions	2014-12-31	No
Has the plan failed to provide any benefit when due under the plan	2014-12-31	No
Contributions received in cash from employer	2014-12-31	$91,590
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2014-12-31	$165,566
Contract administrator fees	2014-12-31	$2,180
Did the plan have assets held for investment	2014-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2014-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2014-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2014-12-31	Disclaimer
Accountancy firm name	2014-12-31	MCGLADREY LLP
Accountancy firm EIN	2014-12-31	470714325
2013 : PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN 2013 401k financial data
Total unrealized appreciation/depreciation of assets	2013-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2013-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2013-12-31	$0
Total income from all sources (including contributions)	2013-12-31	$1,660,231
Total loss/gain on sale of assets	2013-12-31	$0
Total of all expenses incurred	2013-12-31	$436,074
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2013-12-31	$411,019
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2013-12-31	$693,598
Value of total assets at end of year	2013-12-31	$5,154,977
Value of total assets at beginning of year	2013-12-31	$3,930,820
Total of administrative expenses incurred including professional, contract, advisory and management fees	2013-12-31	$25,055
Total interest from all sources	2013-12-31	$966,633
Total dividends received (eg from common stock, registered investment company shares)	2013-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2013-12-31	No
Was this plan covered by a fidelity bond	2013-12-31	Yes
Value of fidelity bond cover	2013-12-31	$500,000
If this is an individual account plan, was there a blackout period	2013-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2013-12-31	No
Contributions received from participants	2013-12-31	$511,433
Participant contributions at end of year	2013-12-31	$89,996
Participant contributions at beginning of year	2013-12-31	$92,023
Income. Received or receivable in cash from other sources (including rollovers)	2013-12-31	$94,953
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Value of net income/loss	2013-12-31	$1,224,157
Value of net assets at end of year (total assets less liabilities)	2013-12-31	$5,154,977
Value of net assets at beginning of year (total assets less liabilities)	2013-12-31	$3,930,820
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2013-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2013-12-31	No
Were any leases to which the plan was party in default or uncollectible	2013-12-31	No
Investment advisory and management fees	2013-12-31	$22,365
Value of interest in pooled separate accounts at end of year	2013-12-31	$4,719,424
Value of interest in pooled separate accounts at beginning of year	2013-12-31	$3,593,041
Interest on participant loans	2013-12-31	$3,535
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2013-12-31	$963,098
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2013-12-31	$345,557
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2013-12-31	$245,756
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2013-12-31	No
Was there a failure to transmit to the plan any participant contributions	2013-12-31	No
Has the plan failed to provide any benefit when due under the plan	2013-12-31	No
Contributions received in cash from employer	2013-12-31	$87,212
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2013-12-31	$411,019
Contract administrator fees	2013-12-31	$2,690
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2013-12-31	No
Did the plan have assets held for investment	2013-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2013-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2013-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2013-12-31	Disclaimer
Accountancy firm name	2013-12-31	MCGLADREY LLP
Accountancy firm EIN	2013-12-31	470714325
2012 : PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN 2012 401k financial data
Total unrealized appreciation/depreciation of assets	2012-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2012-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2012-12-31	$0
Total income from all sources (including contributions)	2012-12-31	$1,007,624
Total loss/gain on sale of assets	2012-12-31	$0
Total of all expenses incurred	2012-12-31	$61,748
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2012-12-31	$42,426
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2012-12-31	$577,156
Value of total assets at end of year	2012-12-31	$3,930,820
Value of total assets at beginning of year	2012-12-31	$2,984,944
Total of administrative expenses incurred including professional, contract, advisory and management fees	2012-12-31	$19,322
Total interest from all sources	2012-12-31	$430,468
Total dividends received (eg from common stock, registered investment company shares)	2012-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2012-12-31	No
Was this plan covered by a fidelity bond	2012-12-31	Yes
Value of fidelity bond cover	2012-12-31	$400,000
If this is an individual account plan, was there a blackout period	2012-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2012-12-31	No
Contributions received from participants	2012-12-31	$468,409
Participant contributions at end of year	2012-12-31	$92,023
Participant contributions at beginning of year	2012-12-31	$36,907
Income. Received or receivable in cash from other sources (including rollovers)	2012-12-31	$32,679
Administrative expenses (other) incurred	2012-12-31	$175
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2012-12-31	No
Value of net income/loss	2012-12-31	$945,876
Value of net assets at end of year (total assets less liabilities)	2012-12-31	$3,930,820
Value of net assets at beginning of year (total assets less liabilities)	2012-12-31	$2,984,944
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2012-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2012-12-31	No
Were any leases to which the plan was party in default or uncollectible	2012-12-31	No
Investment advisory and management fees	2012-12-31	$16,927
Value of interest in pooled separate accounts at end of year	2012-12-31	$3,593,041
Value of interest in pooled separate accounts at beginning of year	2012-12-31	$2,696,917
Interest on participant loans	2012-12-31	$1,945
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2012-12-31	$428,523
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2012-12-31	$245,756
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2012-12-31	$251,120
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2012-12-31	No
Was there a failure to transmit to the plan any participant contributions	2012-12-31	No
Has the plan failed to provide any benefit when due under the plan	2012-12-31	No
Contributions received in cash from employer	2012-12-31	$76,068
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2012-12-31	$42,426
Contract administrator fees	2012-12-31	$2,220
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2012-12-31	No
Did the plan have assets held for investment	2012-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2012-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2012-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2012-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2012-12-31	Disclaimer
Accountancy firm name	2012-12-31	MCGLADREY LLP
Accountancy firm EIN	2012-12-31	470714325

Form 5500 Responses for PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN

2019: PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN 2019 form 5500 responses
2019-01-01	Type of plan entity	Single employer plan
2019-01-01	Submission has been amended	No
2019-01-01	This submission is the final filing	Yes
2019-01-01	This return/report is a short plan year return/report (less than 12 months)	Yes
2019-01-01	Plan is a collectively bargained plan	No
2019-01-01	Plan funding arrangement – Insurance	Yes
2019-01-01	Plan funding arrangement – Trust	Yes
2019-01-01	Plan benefit arrangement – Insurance	Yes
2019-01-01	Plan benefit arrangement - Trust	Yes
2018: PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN 2018 form 5500 responses
2018-01-01	Type of plan entity	Single employer plan
2018-01-01	Submission has been amended	No
2018-01-01	This submission is the final filing	No
2018-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2018-01-01	Plan is a collectively bargained plan	No
2018-01-01	Plan funding arrangement – Insurance	Yes
2018-01-01	Plan funding arrangement – Trust	Yes
2018-01-01	Plan benefit arrangement – Insurance	Yes
2018-01-01	Plan benefit arrangement - Trust	Yes
2017: PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN 2017 form 5500 responses
2017-01-01	Type of plan entity	Single employer plan
2017-01-01	Submission has been amended	No
2017-01-01	This submission is the final filing	No
2017-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2017-01-01	Plan is a collectively bargained plan	No
2017-01-01	Plan funding arrangement – Insurance	Yes
2017-01-01	Plan funding arrangement – Trust	Yes
2017-01-01	Plan benefit arrangement – Insurance	Yes
2017-01-01	Plan benefit arrangement - Trust	Yes
2016: PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN 2016 form 5500 responses
2016-01-01	Type of plan entity	Single employer plan
2016-01-01	Submission has been amended	No
2016-01-01	This submission is the final filing	No
2016-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2016-01-01	Plan is a collectively bargained plan	No
2016-01-01	Plan funding arrangement – Insurance	Yes
2016-01-01	Plan funding arrangement – Trust	Yes
2016-01-01	Plan benefit arrangement – Insurance	Yes
2016-01-01	Plan benefit arrangement - Trust	Yes
2015: PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN 2015 form 5500 responses
2015-01-01	Type of plan entity	Single employer plan
2015-01-01	Submission has been amended	No
2015-01-01	This submission is the final filing	No
2015-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2015-01-01	Plan is a collectively bargained plan	No
2015-01-01	Plan funding arrangement – Insurance	Yes
2015-01-01	Plan benefit arrangement – Insurance	Yes
2014: PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN 2014 form 5500 responses
2014-01-01	Type of plan entity	Single employer plan
2014-01-01	Submission has been amended	No
2014-01-01	This submission is the final filing	No
2014-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2014-01-01	Plan is a collectively bargained plan	No
2014-01-01	Plan funding arrangement – Insurance	Yes
2014-01-01	Plan benefit arrangement – Insurance	Yes
2013: PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN 2013 form 5500 responses
2013-01-01	Type of plan entity	Single employer plan
2013-01-01	Submission has been amended	No
2013-01-01	This submission is the final filing	No
2013-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2013-01-01	Plan is a collectively bargained plan	No
2013-01-01	Plan funding arrangement – Insurance	Yes
2013-01-01	Plan benefit arrangement – Insurance	Yes
2012: PHARMACEUTICAL TECHNOLOGIES, INC. 401(K) PLAN 2012 form 5500 responses
2012-01-01	Type of plan entity	Single employer plan
2012-01-01	Submission has been amended	Yes
2012-01-01	This submission is the final filing	No
2012-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2012-01-01	Plan is a collectively bargained plan	No
2012-01-01	Plan funding arrangement – Insurance	Yes
2012-01-01	Plan benefit arrangement – Insurance	Yes

Insurance Providers Used on plan

MINNESOTA LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 66168 )

Policy contract number

068913

Policy instance

Insurance contract or identification number	068913
Number of Individuals Covered	0
Insurance policy start date	2018-01-01
Insurance policy end date	2018-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $0
Are there contracts with allocated funds for individual policies?	0
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	No
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

MINNESOTA LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 66168 )

Policy contract number

68913

Policy instance

Insurance contract or identification number	68913
Number of Individuals Covered	171
Insurance policy start date	2017-01-01
Insurance policy end date	2017-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $0
Are there contracts with allocated funds for individual policies?	0
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	No
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

MASSACHUSETTS MUTUAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 65935 )

Policy contract number

81806

Policy instance

Insurance contract or identification number	81806
Number of Individuals Covered	139
Insurance policy start date	2015-01-01
Insurance policy end date	2015-12-31
Total amount of commissions paid to insurance broker	USD $16,777
Total amount of fees paid to insurance company	USD $0
Are there contracts with allocated funds for individual policies?	No
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	No
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No
Commission paid to Insurance Broker	USD $8,962
Insurance broker organization code?	3
Insurance broker name	F.N. KELLEY

MASSACHUSETTS MUTUAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 65935 )

Policy contract number

81806

Policy instance

Insurance contract or identification number	81806
Number of Individuals Covered	135
Insurance policy start date	2014-01-01
Insurance policy end date	2014-12-31
Total amount of commissions paid to insurance broker	USD $14,747
Total amount of fees paid to insurance company	USD $0
Are there contracts with allocated funds for individual policies?	No
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	No
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No
Commission paid to Insurance Broker	USD $7,879
Insurance broker organization code?	3
Insurance broker name	F.N. KELLEY

MASSACHUSETTS MUTUAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 65935 )

Policy contract number

81806

Policy instance

Insurance contract or identification number	81806
Number of Individuals Covered	129
Insurance policy start date	2013-01-01
Insurance policy end date	2013-12-31
Total amount of commissions paid to insurance broker	USD $12,531
Total amount of fees paid to insurance company	USD $0
Are there contracts with allocated funds for individual policies?	No
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	No
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No
Commission paid to Insurance Broker	USD $6,701
Insurance broker organization code?	3
Insurance broker name	F.N. KELLEY

MASSACHUSETTS MUTUAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 65935 )

Policy contract number

81806

Policy instance

Insurance contract or identification number	81806
Number of Individuals Covered	120
Insurance policy start date	2012-01-01
Insurance policy end date	2012-12-31
Total amount of commissions paid to insurance broker	USD $10,043
Total amount of fees paid to insurance company	USD $0
Are there contracts with allocated funds for individual policies?	No
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	No
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No
Commission paid to Insurance Broker	USD $5,404
Insurance broker organization code?	3
Insurance broker name	F.N. KELLEY

Potentially related plans

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	PHARMACEUTICAL TECHNOLOGIES, INC.
Employer identification number (EIN):	470818115
NAIC Classification:	524290

Jurisdiction of Incorporation:	Washington Secretary of State Corporations Division
Incorporation Date:	2014-06-18
Company Identification Number:	603412528
Legal Registered Office Address:	300 DESCHUTES WAY SW STE 208 MC-CSC1 TUMWATER United States of America (USA) 98501